We are delighted to announce that CITIID has completed a successful move to the Jeffrey Cheah Biomedical Centre (JCBC).

The JCBC is the latest addition to the Cambridge Biomedical Campus, the largest biotech cluster outside the United States. The six storey 18,000 square metre building houses state-of-the-art laboratory facilities for CITIID groups with expertise in autoimmune and inflammatory disease, fundamental immunology, and infectious disease research.

The institute is centrally placed in the thriving Cambridge Biomedical Campus, home to Europe’s largest internationally competitive concentration of health care-related talent and enterprise. This is adjacent to the 1,100 bed Addenbrooke’s Hospital, Royal Papworth Hospital, the MRC Laboratory of Molecular Biology (with its 12 Nobel prizes) and AstraZeneca’s Global Research and Development Centre, among many others.